St. Joseph Medical Center Extends Oncology Services with Outpatient Locations

St. Joseph Medical Center Extends Oncology Services with Outpatient Locations

Acquires Two Cancer Treatment Centers in the Medical Center and West Houston

HOUSTON (November 5, 2015) – St. Joseph Medical Center (SJMC) announced today that it has completed the acquisition of two cancer treatment centers located in Houston to extend its oncology point of service beyond its main downtown hospital.

The two centers had been under the sole operation of Sightline Health, an affiliate of Integrated Oncology Network (ION) based in California, and are located near the Texas Medical Center and in West Houston. They have been rebranded as St. Joseph Cancer Center and will operate as outpatient departments of the hospital offering breakthrough technologies to deliver hope to individuals battling cancer including: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), High-Dose Rate (HDR) Brachytherapy and AccuBoost® for breast conservation therapy (BCT).

ION is a radiation oncology management company that develops cancer centers for physician practices and hospitals. “We are honored to partner with a leading hospital like St. Joseph on a cancer center offering advanced therapies, and quality, cost-efficient patient care,” said Jeffrey Goffman, CEO and co-founder of ION.

“This acquisition is part of our strategic plan to extend St. Joseph’s reach beyond downtown and to deliver high quality healthcare services to more Houstonians,” said Mark Bernard, CEO of SJMC. “The November 2012 opening of St. Joseph Medical Center in the Heights began this initiative and it continues today as the cancer centers offer advanced treatments delivered by dedicated teams of nurses and staff who have all transitioned to be part of St. Joseph.”

Radiation oncologist Sanjay C. Mehta, M.D. will continue to plan and oversee the treatment process for patients at the two centers. His primary focus is providing patients with a personalized treatment plan and an environment conducive to optimal recovery.

“IMRT and IGRT therapies are exceptional technologies for cancer treatment,” said Dr. Mehta. “IMRT is an extremely precise method of computer modeling and delivering external beam radiation therapy, and IGRT with a cone beam CT scanner takes this technology further by allowing us to adjust daily for internal organ motion, thereby improving accuracy of tumor targeting, while simultaneously sparing surrounding tissue. This allows us to deliver cancer treatment more precisely and with less side effects, and both are beneficial for many different types of cancer.”

St. Joseph Cancer Centers are located at 9150 S. Main St. and 2610 W. Sam Houston Parkway South.

Top news

Back to all news

Top news

Back to all news